Why Conjoint Analysis Matters in MedTech
In MedTech, decisions are rarely based on a single factor — they involve complex trade-offs between clinical performance, workflow impact, economic value, and price. Conjoint analysis matters because it replicates this reality, forcing respondents to make choices between competing product configurations in a way that closely mirrors real-world decision-making. Rather than asking what stakeholders say is important, it reveals what actually drives choice. This enables MedTech companies to move beyond assumption and intuition, providing a robust, quantitative foundation to inform product design, pricing strategy, value proposition, and commercial business cases with confidence.
Conjoint analysis helps by quantifying:
What drives choice between competing medical device solutions
Understanding which attributes truly influence decision-making — and which have limited impact.
How stakeholders trade off price vs clinical and operational value
Measuring willingness to pay and identifying price sensitivity across segments.
Which product configurations maximise adoption and commercial success
Defining the optimal combination of features, performance, and pricing.
This clarity supports evidence-based decision-making across product development, pricing, and commercial strategy.